These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 23937271
1. Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study. Lee WK, Lee SH, Cho ST, Lee YS, Oh CY, Yoo C, Cho JS, Lee SK, Yang DY. J Sex Med; 2013 Nov; 10(11):2832-41. PubMed ID: 23937271 [Abstract] [Full Text] [Related]
5. The Combination of Dapoxetine and Behavioral Treatment Provides Better Results than Dapoxetine Alone in the Management of Patients with Lifelong Premature Ejaculation. Cormio L, Massenio P, La Rocca R, Verze P, Mirone V, Carrieri G. J Sex Med; 2015 Jul; 12(7):1609-15. PubMed ID: 26077706 [Abstract] [Full Text] [Related]
10. Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study. Tuken M, Culha MG, Serefoglu EC. Int J Impot Res; 2019 Mar; 31(2):92-96. PubMed ID: 30705437 [Abstract] [Full Text] [Related]
11. Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial. Abu El-Hamd M, Abdelhamed A. Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497478 [Abstract] [Full Text] [Related]
12. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials. Porst H, McMahon CG, Althof SE, Sharlip I, Bull S, Aquilina JW, Tesfaye F, Rivas DA. J Sex Med; 2010 Jun; 7(6):2231-2242. PubMed ID: 20412423 [Abstract] [Full Text] [Related]
14. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine. Shabsigh R, Patrick DL, Rowland DL, Bull SA, Tesfaye F, Rothman M. BJU Int; 2008 Sep 30; 102(7):824-8. PubMed ID: 18647300 [Abstract] [Full Text] [Related]
16. [Evaluation of the efficacy of dapoxetine in primary and secondary forms of premature ejaculation]. Gamidov SI, Popova AY, Shatylko TV, Li KI, Safiullin RI. Urologiia; 2022 Mar 30; (1):46-49. PubMed ID: 35274858 [Abstract] [Full Text] [Related]